Patient Video - What has your treatment experience been for your EGFR-positive lung cancer?
Christi discusses her treatment journey and experiences for her EGFR-positive lung cancer. Having the EGFR exon 19 deletion lung cancer mutation qualified her to have the
targeted therapy amivantamab. She talks about the treatment successes and challenges she has experienced from taking repeated biomarker testing, which revealed she had additional mutations (FGFR1 amplification, FGF3 mutation, NSD3 amplification, and others).
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
